📰 Sun Pharm News
Sun Pharm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sun Pharm. Real-time updates on events, politics, business and more.
June 27, 2024
Thanks to a new way of accounting. 8 00 a. M. Across the emirates. Im Tracy Alloway in dubai. E welcome to Bloomberg Markets middle east. The oil surprise that saudi it looksistered like maybe we are now near overbought territory. Tracy thats exactly right. I thought they would bring a little pessimism entire tuesday show this morning, a little bit of a reality check and some technical analysis. Take a look at this chart. This shows the price of oil, the white line, but more interesting for our ...
January 24, 2024
Ganirelix Market | Ambinter, BLD Pharm, Chemenu
January 10, 2024
Case Name: Orexo AB v. Sun Pharm. Indus. Ltd., Civ. No. 20-12588 (GC/DEA), 2023 WL 4492095 (D.N.J. July 12, 2023) (Castner, J.) - Drug Product and Patent(s)-in-Suit: Zubsolv®...
December 8, 2023
As the generic Adderall shortage extends to Vyvanse and Ritalin, DEA and drug manufacturers trade blame for the ADHD medication shortfall.
November 8, 2023
On August 22, 2023, the U.S. Court of Appeals for the Federal Circuit issued yet another decision reinforcing what can only be described as the “lead compound” rule for challenging pharmaceutical and other chemical compound patents on the basis of obviousness.
October 2, 2023
On August 22, 2023, the Federal Circuit issued a nonprecedential decision holding that claims directed to deuterated analogs of ruxolitinib were unpatentable as obvious. Sun Pharm....
September 29, 2023
On August 22, 2023, the Federal Circuit issued a nonprecedential decision holding that claims directed to deuterated analogs of ruxolitinib were unpatentable as obvious. Sun Pharm. Indus
August 30, 2023
On August 22, 2023, the Federal Circuit affirmed an IPR Final Written Decision holding claims to deuterated derivatives of ruxolitinib unpatentable as obvious and rejected the...
August 21, 2023
Flecainide Market | Amneal Pharm, Ani Pharms, Aurobindo Pharma
May 31, 2023
Markets halted 4-consecutive days winning streak on Wednesday ahead of GDP data, with banking stocks being the top laggards while smallcap stocks outperformed. Despite maintaining outperformance compared to global cues, Sensex fell 0.55% to 62,622.24, while Nifty 50 shed 0.53% to 18,534.40.